# US 2008/0077023 A1 · Method and system for monitoring intracranial pressure

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0077023 A1
- Document ID: US20080077023A1
- Status: Published application
- Kind: A1
- Application number: 11/528,218
- Filed: 2006-09-27
- Published: 2008-03-27
- Earliest claimed: 2006-09-27
- Assignees: Nellcor Puritan Bennett LLC
- Inventors: Shannon E. Campbell; Clark R. Baker
- Web page: https://patentgrep.com/patent/US20080077023A1

## CPC

- A61B 5/031: {Intracranial pressure}
- A61B 5/0205: Simultaneously evaluating both cardiovascular conditions and different types of body conditions, e.g. heart and respiratory condition
- A61B 5/6814: {Head}
- A61B 5/1455: using optical sensors, e.g. spectral photometrical oximeters
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Embodiments of the present invention relate to a system and method for monitoring intracranial pressure. Embodiments of the present invention include emitting an electromagnetic wavelength into forehead tissue of a patient and detecting characteristics of the electromagnetic wavelength after the electromagnetic wavelength has been scattered by the tissue. The characteristics may include variations in the electromagnetic wavelength corresponding to a pulse. Further, embodiments of the present invention include analyzing the variations to identify venous pulsations, and determining whether intracranial pressure is elevated in the patient based on a correlation between the venous pulsations and levels of intracranial pressure.

## Claims

### Claim 1

A method for monitoring intracranial pressure, comprising:
emitting an electromagnetic wavelength into forehead tissue of a patient;
detecting characteristics of the electromagnetic wavelength after the electromagnetic wavelength has been scattered by the tissue, wherein the characteristics include variations in the electromagnetic wavelength corresponding to a pulse;
analyzing the variations to identify venous pulsations; and
determining whether intracranial pressure is elevated in the patient based on a correlation between the venous pulsations and levels of intracranial pressure.

### Claim 2 (depends on 1)

The method of claim 1, comprising:
applying an increasing amount of pressure to the forehead tissue until the venous pulsations are abolished;
measuring the amount of pressure corresponding to abolishment of the venous pulsations; and
quantifying the intracranial pressure based on the measured amount of pressure.

### Claim 3 (depends on 1)

The method of claim 1, comprising:
elevating the forehead tissue relative to the heart of the patient until the venous pulsations are abolished;
measuring the elevation corresponding to abolishment of the venous pulsations; and
quantifying the intracranial pressure based on the measured elevation.

### Claim 4 (depends on 1)

The method of claim 1, comprising analyzing a shape of the variations to identify the venous pulsations based on a correlation between the shape and the venous pulsations.

### Claim 5 (depends on 1)

The method of claim 1, comprising analyzing a phase difference between variations in multiple electromagnetic wavelengths to identify the venous pulsations based on a correlation between the phase difference and the venous pulsations.

### Claim 6 (depends on 1)

The method of claim 1, comprising:
emitting a second electromagnetic wavelength into a different portion of the forehead tissue of the patient;
detecting characteristics of the second electromagnetic wavelength after the second electromagnetic wavelength has been scattered by the different portion of forehead tissue, wherein the characteristics of the second electromagnetic wavelength includes variations in the second electromagnetic wavelength corresponding to pulse; and
comparing a ratio of the variations in the electromagnetic wavelength and the variations in the second electromagnetic wavelength to identify the venous pulsations based on a correlation between the ratio and the venous pulsations.

### Claim 7 (depends on 1)

The method of claim 1, comprising identifying the venous pulsations by comparing a first oxygen saturation estimate obtained from the forehead tissue and a second oxygen saturation estimate from a different portion of the forehead tissue.

### Claim 8 (depends on 1)

The method of claim 1, comprising delivering a pharmaceutical to the patient to control elevated intracranial pressure when elevated intracranial pressure is determined to be present.

### Claim 9 (depends on 1)

The method of claim 1, comprising comparing saturation values from multiple sites or comparing phase differences between a pulse and an ECG to identify the venous pulsations.

### Claim 10

A sensor for monitoring intracranial pressure, comprising:
an emitter configured to emit at least one electromagnetic wavelength into tissue of a patient;
a detector configured to detect the at least one electromagnetic wavelength after scattering by the tissue; and
an adjustment measurement device configured to measure a level of adjustment corresponding to abolishment of venous pulsations detected using the emitter and detector.

### Claim 11 (depends on 10)

The sensor of claim 10, wherein the adjustment measurement device is configured to measure an amount of pressure applied to the sensor.

### Claim 12 (depends on 10)

The sensor of claim 10, wherein the adjustment measurement device comprises a pressure sheet.

### Claim 13 (depends on 10)

The sensor of claim 10, wherein the adjustment measurement device is configured to measure an elevation relative to the heart of the patient.

### Claim 14 (depends on 10)

The sensor of claim 10, comprising a headband configured to adjustably press the sensor against the patient.

### Claim 15

A system for monitoring intracranial pressure, comprising:
a sensor comprising:
an emitter configured to emit at least one electromagnetic wavelength into tissue of a patient; and
a detector configured to detect the at least one electromagnetic wavelength after scattering by the tissue;
a monitor in electronic communication with the sensor, the monitor configured to analyze characteristics of the detected electromagnetic wavelength to identify venous pulsations; and
an adjustment measurement device configured to measure a level of adjustment corresponding to abolishment of identified venous pulsations.

### Claim 16 (depends on 15)

The system of claim 15, comprising:
an inflatable headband; and
a pump configured to inflate the headband to increase pressure between the sensor and the tissue.

### Claim 17 (depends on 15)

The system of claim 15, comprising an adjustable head elevator configured to elevate the tissue with respect to the heart of the patient.

### Claim 18 (depends on 15)

The system of claim 15, wherein the monitor comprises a pressure mapping system.

### Claim 19 (depends on 15)

The system of claim 15, wherein the monitor comprises a pulse oximeter.

### Claim 20

A method, comprising:
providing an emitter configured to emit at least one electromagnetic wavelength into tissue of a patient;
providing a detector configured to detect the at least one electromagnetic wavelength after scattering by the tissue; and
providing an adjustment measurement device configured to measure a level of adjustment corresponding to abolishment of venous pulsations detected using the emitter and detector.

### Claim 21 (depends on 20)

The method of claim 20, wherein the adjustment measurement device is configured to measure an amount of pressure applied to the sensor.

### Claim 22 (depends on 20)

The method of claim 20, wherein the adjustment measurement device comprises a pressure sheet.

### Claim 23 (depends on 20)

The method of claim 20, wherein the adjustment measurement device is configured to measure an elevation relative to the heart of the patient.
